About Us
Core Values
Our Mission
Empowering researchers in translating findings to clinical applications and enabling doctors to match patients with the right treatments at the right time.
Our Vision
To make a groundbreaking shift towards better bone health for all, by enhancing drug development and personalizing treatments.
Empowerment
We empower decision making in all positions
Ambition
We challenge ourselves with ambitious goals
Accountability
We take responsibility for our decisions
Goal-Driven
We are goal-driven
Balance
We balance our workload with personal time
Diligence
We complete what we start
Respect
We communicate respectfully in all situations
Ingenuity
We think outside the box
Our Story
2014
The idea of cell-based 3D bioprinting to create mineralized scaffolds emerged in Ralph Müller's Laboratory of Bone Biomechanics at ETH Zürich.
2017
The first organotypic bone model was successfully printed and grown from stem cells.
2020
We created the first diseased organotypic bone models from osteoblasts of a patient with Osteogenesis Imperfecta. This paved the way for reliable in vitro models for developing more effective treatments for this patient group.
2022
As part of an iPostdoc PHRT, we elevated our impact by increasing Bon3OID™ production capacity.
The first organotypic bone models that integrate osteoclasts were developed. This enhanced capabilities for testing drugs on the full bone remodelling process, and enabled fracture risk assessment.
2023
A team was put together, and CompagOs was incorporated to translate the scientific progress into valuable assets for researchers, doctors, patients, and the healthcare system.
We introduced organotypic bone models containing osteosarcoma cells, which improved capabilities of drug efficacy testing in patients with osteosarcoma.
Future Plans
Our Team
Management Team
Management
Team
Our management team, comprised of seasoned professionals in the field, brings experience and innovative ideas to the table, pushing the boundaries of what is possible in bone health solutions.
Advisory Board
Composed of subject matter experts, our advisory board provides strategic advice, ensuring that we stay ahead of the pack.
Markus Staub
Financial Advisor
Ralph Müller
Science Advisor | Co-Founder
Anil Seti
Business Advisor | Co-Founder
Reto Hartmann
Innosuisse Coach
Markus Staub
Financial Advisor
Anil Seti
Business Advisor | Co-Founder
Reto Hartmann
Innosuisse Coach
Ralph Müller
Science Advisor | Co-Founder
Partnerships
CompagOs is proud to work with a wide range of partners who share our commitment to advancing progress in the field of drug development and personalized medicine in bone health.
Supporters
We are always looking for synergies and partnerships for mutual value creation.
Careers
We encourage you to get in touch with us about potential current and future positions. Additionally, follow us on social media to stay updated on any job openings that may arise. We are always on the lookout for talented individuals to join our team, and we would love to consider you for future roles.
Upcoming Events
Together, at CompagOs, we are creating a healthier future with transformative solutions for bone health. Join us on this exciting journey.
October 9, 2024
Basel, CH
October 18, 2024
Zürich, CH
November 21, 2024
Zürich, CH
News
Stay updated with our latest news, blog articles, collaborations, and more.
News
December 16, 2023
News
